Literature DB >> 7686213

Freezing adhesion molecules in a state of high-avidity binding blocks eosinophil migration.

T W Kuijpers1, E P Mul, M Blom, N L Kovach, F C Gaeta, V Tollefson, M J Elices, J M Harlan.   

Abstract

Leukocyte extravasation is mediated by multiple interactions of adhesive surface structures with ligands on endothelial cells and matrix components. The functional role of beta 1 (CD29) integrins (or very late antigen [VLA] proteins) in eosinophil migration across polycarbonate filters was examined under several in vitro conditions. Eosinophil migration induced by the chemoattractant C5a or platelet-activating factor was fully inhibited by monoclonal antibody (mAb) 8A2, a recently characterized "activating" CD29 mAb. However, inhibition by mAb 8A2 was observed only under filter conditions that best reflected the in vivo situation, i.e., when the eosinophils migrated over filters preincubated with the extracellular matrix (ECM) protein fibronectin (FN), or when the filters were covered with confluent monolayers of cultured human umbilical vein endothelial cells (HUVEC). When bare untreated filters were used, mAb 8A2 had no effect, whereas the C5a-directed movement was prevented by CD18 mAb. Studies with alpha-subunit (CD49)-specific mAbs indicated that the integrins VLA-4 and -5 mediated migration across FN-preincubated filters, and VLA-2, -4, -5, and -6 were involved in eosinophil migration through filters covered with HUVEC. In contrast with the activating CD29 mAb 8A2, a combination of blocking CD49 mAbs or the nonactivating but blocking CD29 mAb AIIB2 failed to inhibit completely eosinophil migration over FN-preincubated or HUVEC-covered filters. mAb 8A2 stimulated binding to FN but not to HUVEC. Moreover, eosinophil migration over FN-preincubated or HUVEC-covered filters was significantly inhibited by anti-connecting segment 1 (CS-1) mAbs, as well as the soluble CS-1 peptide (unlike migration across bare untreated filters). Thus, inhibition of eosinophil migration by mAb 8A2 depended upon the presence of ECM proteins and not upon the presence of HUVEC per se. In conclusion, "freezing" adhesion receptors of the beta 1 integrin family into their high-avidity binding state by the activating CD29 mAb 8A2 results in a complete inhibition of eosinophil migration under physiological conditions. Hence, activation of beta 1 integrin-mediated cell adhesion may represent a new approach to prevent influx of inflammatory cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686213      PMCID: PMC2191076          DOI: 10.1084/jem.178.1.279

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  31 in total

Review 1.  VLA proteins in the integrin family: structures, functions, and their role on leukocytes.

Authors:  M E Hemler
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

2.  Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.

Authors:  A J Wardlaw; R Moqbel; O Cromwell; A B Kay
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

3.  Identification of surface proteins mediating adherence of CD11/CD18-deficient lymphoblastoid cells to cultured human endothelium.

Authors:  B R Schwartz; E A Wayner; T M Carlos; H D Ochs; J M Harlan
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

4.  Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate.

Authors:  P L Bruijnzeel; R A Warringa; P T Kok; J Kreukniet
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

5.  Continuous cell activation is necessary for stable interaction of complement receptor type 3 with its counter-structure in the aggregation response of human neutrophils.

Authors:  T W Kuypers; L Koenderman; R S Weening; A J Verhoeven; D Roos
Journal:  Eur J Immunol       Date:  1990-03       Impact factor: 5.532

6.  Migratory responses of eosinophil and neutrophil granulocytes from patients with asthma.

Authors:  L Håkansson; M Carlson; G Stålenheim; P Venge
Journal:  J Allergy Clin Immunol       Date:  1990-04       Impact factor: 10.793

7.  Synergism between eosinophil cationic protein and oxygen metabolites in killing of schistosomula of Schistosoma mansoni.

Authors:  M Yazdanbakhsh; P C Tai; C J Spry; G J Gleich; D Roos
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

8.  An alternative leukocyte homotypic adhesion mechanism, LFA-1/ICAM-1-independent, triggered through the human VLA-4 integrin.

Authors:  M R Campanero; R Pulido; M A Ursa; M Rodríguez-Moya; M O de Landázuri; F Sánchez-Madrid
Journal:  J Cell Biol       Date:  1990-06       Impact factor: 10.539

9.  Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression.

Authors:  Z Werb; P M Tremble; O Behrendtsen; E Crowley; C H Damsky
Journal:  J Cell Biol       Date:  1989-08       Impact factor: 10.539

10.  Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin.

Authors:  E A Wayner; A Garcia-Pardo; M J Humphries; J A McDonald; W G Carter
Journal:  J Cell Biol       Date:  1989-09       Impact factor: 10.539

View more
  31 in total

1.  Cell adhesion, inflammation and therapy: old ideas and a significant step forward.

Authors:  Roberto González-amaro
Journal:  Acta Pharmacol Sin       Date:  2011-10-31       Impact factor: 6.150

2.  A small molecule agonist of an integrin, alphaLbeta2.

Authors:  Wei Yang; Christopher V Carman; Minsoo Kim; Azucena Salas; Motomu Shimaoka; Timothy A Springer
Journal:  J Biol Chem       Date:  2006-10-05       Impact factor: 5.157

3.  A novel region of the alpha4 integrin subunit with a modulatory role in VLA-4-mediated cell adhesion to fibronectin.

Authors:  M Muñoz; J Serrador; M Nieto; A Luque; F Sánchez-Madrid; J Teixidó
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

4.  Regulation and function of an activation-dependent epitope of the beta 1 integrins in vascular cells after balloon injury in baboon arteries and in vitro.

Authors:  N Koyama; J Seki; S Vergel; E J Mattsson; T Yednock; N L Kovach; J M Harlan; A W Clowes
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

5.  Modulation of in vivo migratory function of alpha 2 beta 1 integrin in mouse liver.

Authors:  W C Ho; C Heinemann; D Hangan; S Uniyal; V L Morris; B M Chan
Journal:  Mol Biol Cell       Date:  1997-10       Impact factor: 4.138

Review 6.  Activation states of blood eosinophils in asthma.

Authors:  M W Johansson
Journal:  Clin Exp Allergy       Date:  2014-04       Impact factor: 5.018

Review 7.  Treatment of delayed-type hypersensitivity with inhibitors of the VLA-4 integrin.

Authors:  S Tamraz; T Arrhenius; A Chiem; M J Forrest; F C Gaeta; Y B He; J Lei; A Maewal; M L Phillips; L W Vollger
Journal:  Springer Semin Immunopathol       Date:  1995

Review 8.  Pathophysiological aspects of VLA-4 interactions and possibilities for therapeutical interventions.

Authors:  T W Kuijpers
Journal:  Springer Semin Immunopathol       Date:  1995

Review 9.  Biology of the eosinophil.

Authors:  Carine Blanchard; Marc E Rothenberg
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

10.  Differential regulation of beta 1 and beta 2 integrin avidity by chemoattractants in eosinophils.

Authors:  C Weber; J Kitayama; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.